Sage Therapeutics (NASDAQ:SAGE) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Sage Therapeutics missed estimated earnings by 1.47%, reporting an EPS of $-2.07 versus an estimate of $-2.04.
Revenue was down $1.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 5.59% increase in the share price the next day.
Here’s a look at Sage Therapeutics’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -2.17 | -1.85 | -1.69 | -1.91 |
| EPS Actual | -2.12 | -2.21 | -1.83 | -1.64 |
| Revenue Estimate | 1.97M | 1.96M | 2.01M | 2.00M |
| Revenue Actual | 1.64M | 1.44M | 1.64M | 1.58M |
To track all earnings releases for Sage Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.